cell therapy manufacturing
cell therapy manufacturing
Lonza Partners with Acumen for Alzheimer’s Breakthrough
📰 Lonza teams up with Acumen to make sabirnetug, a groundbreaking Alzheimer's therapy, at their New Hampshire facility. 👥 🧪 Sabirnetug targets toxic amyloid beta oligomers, offering hope in the fight against Alzheimer's. 💡 ⏩ Exciting collaboration to speed up Alzheimer's treatment development. Lonza Acumen AlzheimersTherapy Sabirnetug
Boost mRNA Manufacturing with Digital Optimization
📰 Researchers in Germany developed a digital model to optimize mRNA manufacturing, resulting in increased production and reduced truncation. 💻💉
Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies
🔍 Monoclonal antibodies (mAbs) have paved the way for advanced therapies, thanks to decades of development and manufacturing improvements. 💪
FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!
📢 The FDA published new guidance for CAR-T cell products, covering change management, risk assessment, flow cytometry, and more. 👩🔬🔬🧪🗂 CAR-T FDA
Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!
🤖🔬 Researchers suggest that robots and AI can address manufacturing challenges in cell and gene therapy. ⬆️🌍 The industry is growing rapidly, requiring skilled personnel and increased production. 🤖🔬 Automation and AI can improve efficiency and reduce costs.
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
NanoString Acquired Slide Tags in Early Access Cellares Revolutionizes Cell Therapy Manufacturing!
👥 Authors: Alex Philippidis, Uduak Thomas, Jonathan D. Grinstein, PhD, and Corinna Singleman, PhD. 🗓️ Published on March 15, 2024. 💼 NanoString acquired, Slide Tags enter early access as Curio Trekker, and Cellares reveals cell therapy manufacturing platform.
Game-Changing Cancer Immunotherapy Deal Unveiled
📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝
Revolutionizing Cell Therapy: Diversify Collaborate and Optimize
Title: 📝 Improving Cell Therapy Supply Chains: Insights from Pluri, an Israeli Cell Therapy Company Excerpt: Pluri advises advanced therapy manufacturers to diversify, collaborate, and build strong relationships with suppliers for optimal supply chains.
Revolutionary Cell Shuttle: Transforming Cell Therapy Manufacturing
📢 Cellares unveils Cell Shuttle, a clinically-compliant cell therapy manufacturing platform to meet global patient demand and reduce costs. 💉🚀🔬🎯💪🌐
